Results 101 to 110 of about 15,432 (213)

Serological Study of Visceral Leishmaniasis in Boyer Ahmad Township in 2005

Armaghane Danesh Bimonthly Journal, 2007
Introduction & Objective: Visceral leishmaniasis (Kala-azar) is a disease caused by intracellular protozoa parasites of the genus Leishmania. Kala–azar in Iran is usually seen in children below 10 years old.
B Sarkari, AA Moshfe, N Pedram, MA Zargar, B Yazdanpanah, B Akhondi, Z Hasani, M Mohebali   +7 more
doaj  

Application of kDNA as a molecular marker to analyse Leishmania infantum diversity in Portugal.

, 2006
Around the Mediterranean basin Leishmania infantum is an important parasite causing canine leishmaniasis and visceral and cutaneous clinical forms in both immunocompetent and immunocompromised humans.
Almeida, Ana, Campino, Lenea, Cortes, Sofia, Cristovão, José Manuel, Dedet, Jean Pierre, Mauricio, Isabel, Pratlong, Francine   +6 more
core   +1 more source

Mapping of risk prone areas of kala-azar (Visceral leishmaniasis) in parts of Bihar state, India: An RS and GIS approach [PDF]

, 2006
Background & objectives: The kala-azar fever (Visceral leishmaniasis) is continuing unabated in India for over a century, now being largely confined to the eastern part of India mainly in Bihar state and to some extent in its bordering states like ...
Battacharya, SK, Kar, SK, Palit, A, Srinivas, T, Sudhakar, S   +4 more
core  

Evaluation and comparison of indirect immunofluorescent antibodytest (IFAT) and Direct agglutination test (DAT) using standardized antigen in diagnosis of visceral leishmaniasis

Journal of Mazandaran University of Medical Sciences, 2005
Background and purpose : Human visceral leishmaniasis (HVL) is endemic in several foci in IRAN, such as Ardebil and Fars provinces (in North western and southern parts of IRAN) and in some regions as sporadic.
M. Ghasemi, H. Hejaziv, D. Dorostkar Moghaddam   +2 more
doaj  

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial [PDF]

, 2017
This randomized, open sequential design trial was set up to assess the efficacy, tolerability and toxicity of 20 d courses of combined intramuscular aminosidine and sodium stibogluconate at various dosages in patients with newly-diagnosed kala-azar in ...
Bhowmick, S., Dolfi, L., Olliaro, P., Thakur, C.P.   +3 more
core  

Kala-Azar: A Case Report. [PDF]

Cureus, 2023
Jancar N, Sousa Gonçalves F, Duro J, Pinto I, Oliveira T, Aguiar P.   +5 more
europepmc   +1 more source

Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis. [PDF]

PLoS Negl Trop Dis, 2023
Roy M, Ceruti A, Kobialka RM, Roy S, Sarkar D, Wahed AAE, Chatterjee M.   +6 more
europepmc   +1 more source

Safety and Effectiveness of Miltefosine in Post-Kala-Azar Dermal Leishmaniasis: An Observational Study. [PDF]

Open Forum Infect Dis, 2023
Sundar S, Singh J, Dinkar A, Agrawal N.
europepmc   +1 more source

Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel. [PDF]

, 2005
Bailey, MS, Beeching, NJ, Bryceson, AD, Chiodini, PL, Ellis, CJ, Green, AD, Lockwood, DN, O'Dempsey, TJ   +7 more
core   +1 more source

Drug Repurposing for Kala-Azar. [PDF]

Pharmaceutics
Arsić B, Ilić BS, Maier A, Hartung M, Janjić J, Milićević J, Baumbach J.   +6 more
europepmc   +1 more source